Silence Therapeutics plc Shares Outstanding (Cover Page)
Silence Therapeutics plc (SLN) had Shares Outstanding (Cover Page) of 141.74 million shares as of 2026-07-31, per its 10-Q filed 2026-08-10.
Financial Statements › Notes › Cover Page
dei:EntityCommonStockSharesOutstanding · last filed 2026-08-10
- 2026-07-31: Entity Common Stock, Shares Outstanding 141.74M shares.
- 2026-04-30: Entity Common Stock, Shares Outstanding 141.70M shares.
- 2026-01-31: Entity Common Stock, Shares Outstanding 141.70M shares.
- 2025-10-30: Entity Common Stock, Shares Outstanding 141.70M shares.
| Period end | Entity Common Stock, Shares Outstanding |
|---|---|
| 2026-07-31 | 141.74M shares 10-Q · filed 2026-08-10 |
| 2026-04-30 | 141.70M shares 10-Q · filed 2026-05-07 |
| 2026-01-31 | 141.70M shares 10-K · filed 2026-03-05 |
| 2025-10-30 | 141.70M shares 10-Q · filed 2025-11-06 |
| 2025-07-31 | 141.70M shares 10-Q · filed 2025-08-07 |
| 2025-04-30 | 141.69M shares 10-Q · filed 2025-05-08 |
| 2025-04-21 | 141.69M shares 10-K/A · filed 2025-04-30 |
| 2025-01-31 | 141.67M shares 10-K · filed 2025-02-27 |
| 2023-12-31 | 118.85M shares 20-F · filed 2024-03-13 |
| 2022-12-31 | 107.81M shares 20-F · filed 2023-03-15 |
| 2021-12-31 | 89.78M shares 20-F · filed 2022-03-17 |
| 2020-12-31 | 83.31M shares 20-F/A · filed 2021-04-29 |